NCT05581732

Brief Summary

The goal of this low-interventional study was to study the effect of additional nutritional support with ONS "Nutrinidrink with dietary fiber" on the anthropometric parameters of patients and the dynamics of gastrointestinal symptoms in patients with cerebral palsy. Among the additional objectives were to study the quality of life, metabolic parameters and the dynamics of some functional parameters of patients. Possible adverse events were also studied and described.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 14, 2022

Completed
Last Updated

January 26, 2023

Status Verified

January 1, 2023

Enrollment Period

1 year

First QC Date

October 12, 2022

Last Update Submit

January 24, 2023

Conditions

Keywords

Cerebral PalsyNutritionQuality of LifeBioimpedanceZ-score

Outcome Measures

Primary Outcomes (5)

  • BMI

    Body Mass Index

    during observation up to 16 weeks

  • Z-score (BMI)

    Body mass index z-scores are measures of relative weight adjusted for child age and sex

    during observation up to 16 weeks

  • Bioelectrical impedance analysis

    Device-based diagnostics to measure the voltage of weak electrical currents in order to calculate impedance (resistance) of the body

    during observation up to 16 weeks

  • Gastrointestinal symptoms scale

    A patient reported 5 score questionnaire to evaluate frequency and severity of gastrointestinal symptoms with 1 - minimal symptom manifestation, 5 - maximal symptom manifestation

    during observation up to 16 weeks

  • Martinet-Kushelevsky test

    Activity test to determine the level of physical abilities

    during observation up to 16 weeks

Study Arms (2)

Study

32 patients in the study group received supplemental nutritional support with ONS "Nutrinidrink with Dietary Fiber" in a pre-calculated amount daily throughout the study for 14-16 weeks. During the hospital stay, additional nutritional support was added to the patient's standard hospital diet (ATC table). On an outpatient basis, the patient received the required amount of ONS at his disposal and add it as a supplement to his/her usual and habitual diet between main meals.

Dietary Supplement: Nutrinidrink with Dietary Fiber

Control

24 patients in the control group adhered to the standard hospital diet (ATC table), and at discharge - the usual habitual diet

Interventions

Nutrinidrink with Dietary Fiber is a specialized nutrition for children during illness and recovery period, as well as with increased protein and energy needs: mental and / or physical stress, chronic diseases, growth and / or weight deficiency

Study

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Boys and girls, aged 4-8 years with confirmed diagnosis of cerebral palsy, spastic and hyperkinetic forms (Class of cerebral palsy GMFCS 2-3) and Z-score BMI ≤ -1

You may qualify if:

  • Confirmed diagnosis of cerebral palsy, spastic and hyperkinetic forms;
  • Class of cerebral palsy GMFCS 2-3;
  • Z-score BMI ≤ -1;
  • The patient's ability to safely swallow liquid food;

You may not qualify if:

  • Individual intolerance to the investigational product components;
  • Galactosemia;
  • Allergy to cow's milk proteins and other food intolerances;
  • Participation in another clinical study currently or in the past 30 days;
  • Any other medical or non-medical reason that, in the physician's opinion, may prevent the patient from participating in the study.
  • Deterioration of the patient's condition requiring his transfer to enteral or parenteral nutrition;
  • Transfer of a patient to another hospital;
  • Complications that could be caused by the investigational product (diarrhea, nausea, vomiting, allergies, etc.);
  • Withdrawal for a safety reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Center for nutrition and biotechnology

Moscow, Russia

Location

Scientific and Clinical Center for Children's Psychoneurology

Moscow, Russia

Location

Child's Clinical Hospital by Ivanova

Samara, Russia

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Dietary Fiber

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Mikhail A Getman, Dr

    Enrollme.ru

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2022

First Posted

October 14, 2022

Study Start

June 1, 2021

Primary Completion

June 1, 2022

Study Completion

August 1, 2022

Last Updated

January 26, 2023

Record last verified: 2023-01

Locations